Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIVE platform phase 3 trial of ensitrelvir in hospitalized adults with COVID-19
jRCT2031220667Phase 3Completed
- Sponsor
- International Sponsor:University of Minnesota Sponsor:The University of New South Wales
- Start
- Jun 2023
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Ensitrelvir plus standard of care with Placebo plus standard of care (2 arms). Primary endpoint: Days to Recovery Scale through Day 60. Started Jun 2023; status: completed.
02
Drugs
ensitrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2031220667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220667.